Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening
Grant L. Lin(Stanford University), Michelle Monje(Howard Hughes Medical Institute), Kelli M. Wilson(National Institutes of Health), Damien Duveau(National Institutes of Health), Craig J. Thomas(National Institutes of Health), Aleksandra M. Michalowski(National Institutes of Health), Katherine E. Warren(Brigham and Women's Hospital), Shawn Gillespie(Broad Institute), Katrin I. Andreasson(Neurosciences Institute), James Lennon(Stanford University), Pamelyn J. Woo(Stanford University), Nicholas A. Vitanza(Seattle Children's Hospital), Sara Kreimer(Stanford University), Zina Itkin(National Institutes of Health), Paras S. Minhas(Brigham and Women's Hospital), Carleen Klumpp‐Thomas(National Institutes of Health), Michele Ceribelli(National Institutes of Health), Eric H. Raabe(Johns Hopkins University), Benjamin Z. Stanton(Nationwide Children's Hospital), Sam Michael(National Institutes of Health), Michael A. Quezada(Stanford University), Reem Ghanem(Stanford University), Rajarshi Guha(Vertex Pharmaceuticals (United States)), Surya Nagaraja(Stanford University), Patrick J. Morris(National Institutes of Health), Anna C. Geraghty(Stanford University), Lu Chen(Chengdu University of Traditional Chinese Medicine), Xiaohu Zhang(Soochow University), Crystal McKnight(National Institutes of Health), Elizabeth Y. Qin(Stanford University), Marc Ferrer(National Institute of Biomedical Innovation, Health and Nutrition), Paul Shinn(National Institutes of Health), Lijun Ni(Stanford University)
Cited by 259